In partnership with Dr Bart Dolmatch at Palo Alto Medical Foundation, the company developed the device in 2010.
The single-use product is surgically implanted for arterial replacement and repair after a traumatic injury to the extremity.
With approval, the company can begin commercializing the device in the U.S. in 2025.
Merit stated that Wrapsody is designed to extend long-term vessel patency in dialysis patients. The device’s covering features a nitinol stent frame enveloped by an expandable polytetrafluoroethylene ...